Parul Nafees Barry

Parul Barry practices at UPMC Presbyterian in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center.

Parul Barry's NPI, 1255621157, was assigned on April 12, 2011. Parul Barry holds Pennsylvania license MD470707.

Parul Barry's primary practice is UPMC Presbyterian, at 200 Lothrop Street, Pittsburgh, PA 15213 in Allegheny County. The practice phone is (412) 647-2345.

Parul Barry's primary practice is UPMC Presbyterian in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center. Parul Barry is also affiliated with Select Specialty Hospital - Pittsburgh / UPMC. The medical group on file is University of Pittsburgh Physicians, Department of Radiology. Dmand AI also links Parul Barry to 4 more hospitals and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Parul Barry practices, 6 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Parul Barry's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Parul Barry is licensed in Pennsylvania.

CMS data shows 679 Medicare services from Parul Barry across 13 procedure codes in 2024, for 160 Medicare patients. Medicare paid $37,759 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 160 Medicare patients who saw Parul Barry in 2024. The largest group is 65 to 74, with 92 patients. 75% of them have cancer, and 70% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.27, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Parul Barry's median patient age at 70, with 93% women.

In 2024, Parul Barry wrote 72 Medicare Part D claims for 38 patients. 99% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $89 in total drug cost. In 2020, CMS named 30 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Parul Barry for performance year 2024, reported as part of a group. Parul Barry accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 23 papers to Parul Barry, published from 2019 to 2025. 2021 was the busiest year, with 5. The most frequent topics are Radiotherapy Dosage, Brachytherapy and Endometrial Neoplasms. Parul Barry has published most often in Adv Radiat Oncol. Parul Barry's most frequent co-authors are Sushil Beriwal, MD, Adrianna Henson Masters, MD, PhD and Dian Wang, MD.

CMS Open Payments shows 46 general payments to Parul Barry from 22 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 39% of the total. Novartis Pharmaceuticals Corporation paid the most, $1,760.